1. Home
  2. LYTS vs RAPP Comparison

LYTS vs RAPP Comparison

Compare LYTS & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSI Industries Inc.

LYTS

LSI Industries Inc.

HOLD

Current Price

$19.19

Market Cap

700.9M

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.34

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYTS
RAPP
Founded
1976
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
700.9M
1.2B
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
LYTS
RAPP
Price
$19.19
$30.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$27.50
$47.80
AVG Volume (30 Days)
156.1K
361.1K
Earning Date
01-22-2026
11-06-2025
Dividend Yield
1.04%
N/A
EPS Growth
2.57
N/A
EPS
0.80
N/A
Revenue
$592,531,000.00
N/A
Revenue This Year
$6.26
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
$24.07
N/A
Revenue Growth
22.35
N/A
52 Week Low
$13.77
$6.43
52 Week High
$25.50
$42.27

Technical Indicators

Market Signals
Indicator
LYTS
RAPP
Relative Strength Index (RSI) 50.41 62.22
Support Level $18.72 $27.81
Resistance Level $19.01 $31.00
Average True Range (ATR) 0.45 1.84
MACD 0.29 0.11
Stochastic Oscillator 83.26 83.09

Price Performance

Historical Comparison
LYTS
RAPP

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: